A study to evaluate the synergistic effects on of cabozantinib to temozolomide and bevacizumab in patients with heavily pretreated relapsed uterine leiomyosarcoma.
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2015
At a glance
- Drugs Cabozantinib (Primary) ; Bevacizumab; Temozolomide
- Indications Leiomyosarcoma; Uterine cancer
- Focus Therapeutic Use
- 21 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.